Astragaloside II (Astrasieversianin VIII) is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy. Astragaloside II also induces osteogenic activities, differentiation, proliferation, and mineralization, through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.

Astragalus polysaccharide, a natural product derived from Astragalus propinquus, exhibits anticancer activity and has been shown to be effective in hepatocellular carcinoma (HCC) by inhibiting the M2 polarization of tumor-associated macrophages (TAM).

Kumatakenin can suppress >80% of the SOS-inducing activity of Trp-P-1 at <0.06 micromol/mL.

Cyclocephaloside II is a natural product extracted from the roots of Astragalus brachypterus and Astragalus microcephalus, belonging to the class of cycloalkane triterpenoid saponins with potential biological activities. Astragalus saponin has the effect of improving myocardial function.

Neoastragaloside I is a natural product

Astraganoside is a natural product

Methylnissolin is a natural product from A. membranaceus.

2''-Acetylastragalin is a natural product from Astragalus membranaceus.

Laricitrin is a natural product for research related to life sciences. The catalog number is TN4415 and the CAS number is 53472-37-0.

Laricitrin 3-O-glucoside has antioxidant property.

Complanatoside A (a flavonol glycoside) is isolated from Astragalus complanatus.